세계의 유전자 검사 시장 예측(2025-2030년)

The Global Genetic Testing Market is expected to grow from USD 14.904 billion in 2025 to USD 24.889 billion in 2030, at a CAGR of 10.80%.

The global genetic testing market is experiencing robust growth, driven by an aging population, increasing prevalence of genetic and hereditary diseases, and growing awareness of early disease detection. Technological advancements and expanding applications in preventive healthcare further propel the market. Investments in research and development (R&D) are fostering innovation, positioning genetic testing as a critical tool in medical diagnostics. However, challenges such as high costs, unclear reimbursement structures, lack of skilled personnel, and regulatory gaps may restrain growth. This summary, tailored for industry experts, highlights key drivers, geographical trends, and competitive insights as of 2025.

Market Growth Drivers

The genetic testing market is fueled by the rising incidence of genetic disorders and the growing emphasis on early detection and personalized medicine. An aging global population increases demand for tests to identify hereditary conditions. Technological advancements, including next-generation sequencing and improved testing equipment, enhance accuracy and accessibility, driving adoption across medical and research sectors. Increased R&D investments are accelerating innovation, with new testing methodologies expanding applications in disease prevention and management. However, high testing costs, inconsistent reimbursement policies, and a shortage of skilled professionals pose challenges, particularly in emerging markets where regulatory frameworks are still evolving.

Geographical Outlook

North America dominates the genetic testing market, supported by advanced technological infrastructure, a high prevalence of genetic diseases, and robust R&D investments. The region's well-established healthcare systems and widespread adoption of genetic testing for diagnostics ensure its market leadership. The Asia-Pacific (APAC) region, however, is projected to experience the fastest growth, driven by a rising patient pool, increasing purchasing power, and government funding for healthcare innovation in countries like China and India. Despite this potential, high costs and regulatory uncertainties may limit growth in APAC and other emerging economies.

Research Methodology

The market analysis employs a rigorous methodology, combining secondary data from industry reports and primary inputs from stakeholders for validation. Market size and forecasts are calculated using both top-down and bottom-up approaches, ensuring accuracy. The report segments the market by application, technology, and geography, providing a comprehensive view of trends and opportunities. Industry value chain analysis and Porter's Five Forces model further elucidate market dynamics, regulatory influences, and competitive pressures.

Competitive Insights

Key players in the genetic testing market include F. Hoffmann-La Roche Ltd, 23&Me, Inc., Precipio, Inc., AutoGenomics, Abbott Laboratories, and Luminex Corporation. These companies drive market growth through continuous R&D, product innovation, and strategic partnerships. Their focus on developing advanced testing platforms enhances diagnostic precision and expands market reach. The competitive landscape is shaped by high entry barriers due to significant R&D costs and the need for specialized expertise, consolidating market dominance among established players.

The genetic testing market is poised for significant growth, driven by an aging population, rising genetic disease prevalence, and technological advancements. North America leads, while APAC emerges as a high-growth region due to increasing healthcare investments. Challenges like high costs and regulatory gaps persist, but ongoing R&D and innovation are expected to sustain market expansion. Major players continue to strengthen their positions through advanced solutions, positioning genetic testing as a cornerstone of modern healthcare.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2020 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation

The genetic testing market has been segmented by product type, diseases, technology, and geography:

By Type

• Prenatal Testing
• New Born Screening
• Diagnostic Testing
• Carrier Testing
• Predictive & Pre-symptomatic Testing

By Diseases

• Cancer
• Cystic Fibrosis
• Sickle Cell Anemia
• Duchenne's Muscular Dystrophy
• Alzheimer's Diseases
• Thalassemia
• Huntington's Disease
• Others

By Technology

• Cyto-genetics Testing
• Biochemical Testing
• Molecular Testing
• Others

By Geography

• North America
• United States
• Canada
• Mexico
• Others
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Italy
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• Japan
• China
• India
• Australia
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL GENETIC TESTING MARKET BY TYPE

• 5.1. Introduction
• 5.2. Prenatal Testing
• 5.3. New Born Screening
• 5.4. Diagnostic Testing
• 5.5. Carrier Testing
• 5.6. Predictive & Pre-symptomatic Testing

6. GLOBAL GENETIC TESTING MARKET BY DISEASE

• 6.1. Introduction
• 6.2. Cancer
• 6.3. Cystic Fibrosis
• 6.4. Sickle Cell Anemia
• 6.5. Duchenne's Muscular Dystrophy
• 6.6. Alzheimer's Disease
• 6.7. Thalassemia
• 6.8. Huntington's Disease
• 6.9. Others

7. GLOBAL GENETIC TESTING MARKET BY TECHNOLOGY

• 7.1. Introduction
• 7.2. Cyto-genetics Testing
• 7.3. Biochemical Testing
• 7.4. Molecular Testing
• 7.5. Others

8. GLOBAL GENETIC TESTING MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. United States
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. United Kingdom
  • 8.4.2. Germany
  • 8.4.3. France
  • 8.4.4. Italy
  • 8.4.5. Others
• 8.5. Middle East & Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Others
• 8.6. Asia Pacific
  • 8.6.1. Japan
  • 8.6.2. China
  • 8.6.3. India
  • 8.6.4. Australia
  • 8.6.5. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. F. Hoffmann-La Roche Ltd
• 10.2. Abbott Laboratories
• 10.3. Precipio, Inc.
• 10.4. Ariosa Diagnostics, Inc.
• 10.5. Biocartis SA
• 10.6. Danaher Corporation
• 10.7. 23&Me, Inc.
• 10.8. DiaSorin
• 10.9. Labcorp
• 10.10. AutoGenomics
• 10.11. Illumina, Inc
• 10.12. Thermo Fisher Scientific

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations